Physician profile
Douglas E Thompson
NPI 1891796736
$893.16
in general payments reported to CMS, 2019-2025
10 companies · $48.05 in 2025
The $48.05 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $59.52 · 2021: $110 · 2022: $81.05 · 2023: $188 · 2024: $183 · 2025: $48.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $419.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Midsouth Orthopedics INC. | $163.75 | 2019 | |
| Stryker Corporation | $163.30 | 2020-2025 | Mako, Tritanium |
| Ferring Pharmaceuticals INC. | $163.17 | 2020-2024 | Euflexxa |
| Depuy Synthes Sales INC. | $111.75 | 2019-2025 | Orthovisc, Monovisc |
| Pacira Pharmaceuticals Incorporated | $103.31 | 2021-2024 | Exparel, Iovera, Zilretta |
| Pacira Therapeutics, INC. | $65.76 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $45.87 | 2023 | |
| Bioventus LLC | $33.19 | 2019-2020 | |
| Innovation Technologies INC | $25.18 | 2024 | Irrisept |
| Medline Industries Lp | $17.88 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.